Skip to main content

Find Clinical Trials

Home
Conditions
Varicella Zoster Virus Infection

Clinical trial condition

Varicella Zoster Virus Infection

Explore clinical trials studying Varicella Zoster Virus Infection. Study availability and eligibility vary by location and protocol.

340 public trials 40 recruiting studies

Refine in advanced search Browse all conditions

Varicella Zoster Virus Infection trial results

Completed

Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)

NCT01245751

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)

NCT01556451

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)

NCT01505647

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED)

NCT00546819

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: Not specified

View Trial Details

Completed

V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)

NCT00109343

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)

NCT00534248

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)

NCT00109122

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

NCT00092404

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

Safety Study of a Refrigerator-stable Formulation of VARIVAX®

NCT00432731

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Amboise, France

Ancenis, France

Betton, France

Châteaubriant, France

View all 25 locations

View Trial Details

Completed

ZOSTAVAX® in Renal Transplant Patients

NCT01137669

Conditions: DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations: University of Iowa - Vaccine Research and Education Unit Iowa City, Iowa, United States

University of Maryland Baltimore - School of Medicine - Medicine Baltimore, Maryland, United States

Vanderbilt University - Medicine - Infectious Diseases Nashville, Tennessee, United States

View Trial Details